Evidence map›Paper›PMID 31217899›Full record

ArticleOncotarget2019

Deep sequencing of a recurrent oligodendroglioma and the derived xenografts reveals new insights into the evolution of human oligodendroglioma and candidate driver genes.

Nadin D Exner, Jaime Alberto Campos Valenzuela, Khalil Abou-El-Ardat, Hrvoje Miletic, Peter C Huszthy, Petra M Radehaus, Evelin Schröck, Rolf Bjerkvig, Lars Kaderali, Barbara Klink and 1 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. IDH mutant high-grade gliomas.Frontiers in molecular neuroscience · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 3 countries.

Nadin D ExnerInstitut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Jaime Alberto Campos ValenzuelaInstitut für Medizinische Informatik und Biometrie, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Khalil Abou-El-ArdatInstitut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Hrvoje MileticDepartment of Pathology, Haukeland University Hospital, Bergen, Norway.
Peter C HuszthyOslo University Hospital-Rikshospitalet, Department of Immunology, Oslo, Norway.
Petra M RadehausUniversity of Applied Sciences Mittweida, Department of Applied Informatics & Biosciences, Mittweida, Germany.
Evelin SchröckInstitut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Rolf BjerkvigDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Lars KaderaliUniversity Medicine Greifswald, Institute of Bioinformatics, Greifswald, Germany.
Barbara KlinkInstitut für Klinische Genetik, Medizinische Fakultät Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Janice M NigroDepartment of Biomedicine, University of Bergen, Bergen, Norway.
Hochschule Mittweida · DETechnische Universität Dresden · DEUniversity of Bergen · NOGerman Cancer Research Center · DEHaukeland University Hospital · NOOslo University Hospital · NOUniversitätsmedizin Greifswald · DEUniversity Hospital Carl Gustav Carus · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously reported the establishment of a rare xenograft derived from a recurrent oligodendroglioma with 1p/19q codeletion. Here, we analyzed in detail the exome sequencing datasets from the recurrent oligodendroglioma (WHO grade III, recurrent O

Indexed as

exome sequencingIDH1oligodendrogliomaSNVxenograft

Identifiers

PMID31217899
PMCPMC6557204
OpenAlexW2969436943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.